Maddalena Sansovini - U.C. di Medicina Nucleare e Terapia Radiometabolica, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST-IRCCS)

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 91 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

LBA71 Open-label, Multicentre Randomised Trial of Radium223-docetaxel Versus Docetaxel-Radium223 Sequence in Metastatic Castration Resistant Prostate Cancer (mcrpc) with Prospective Biomarker Evaluation (RAPSON Study)

V. Conteduca,N. Brighi,G. Gurioli,D. Wetterskog,E.F. Giunta,C. Lolli,G. Schepisi,V.E. Chiuri, D. Gasparro, P.A. Zucali,A. Virga, I. Bondi,B. Vertogen,V. Di Iorio,M. Sansovini, S. Severi, E. Scarpi,M. Urbini, G. Attard, U. De Giorgi

Annals of Oncology (2024)

Cited0Views0Bibtex

PS04.14 BLOOD VS VERTEBRAE METHODS FOR BONE MARROW SELF ABSORBED DOSE ESTIMATION IN 177Lu-Psma THERAPY: A CASE STUDY

A. Milano,M.L. Belli, C. Guidi, L. Fantini,P. Caroli,M. Sansovini, F. Matteucci,A. Sarnelli

Physica Medica (2024): 104142

Cited0Views0Bibtex

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

S. Severi,I. Grassi,A. Bongiovanni,A. Sarnelli,V. Di Iorio,N. Ranallo,F. Matteucci,I. Marini,E. Amadori,I. Azzali,N. Riva,L. Gurrieri,S. Nicolini,P. Caroli,M. Sansovini

Journal of nuclear medicine official publication, Society of Nuclear Medicineno. 9 (2024): 1409-1415

Cited0Views0WOSBibtex

Are We Ready to Use PSMA As a Theranostic Biomarker in Clinical Practice for Patients with Breast Cancer

Sara Bravaccini, Alessandra Virga,Flavia Foca, Stefania Cortecchia,Giovanni Martinelli, Sara Ravaioli, Maria Maddalena Tumedei,Federica Matteucci,Roberta Maltoni,Giovanni Paganelli, Francesca Poli,Massimiliano Mazza,Fabio Nicolini,Paola Ulivi,Maddalena Sansovini,Paola Caroli,Maurizio Puccetti

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

¹⁷⁷Lu-PSMA-617 therapy in advanced mCRPC patients: preliminary results of the phase 2 prospective trial IRST-185.03

I. Marini,M. Sansovini,G. Paganelli,I. Grassi,F. Matteucci,S. Nicolini,U. De Giorgi,E. F. Giunta,F. Foca,M. Monti,M. Celli,P. Caroli,V. Di Iorio,A. Sarnelli,C. Lolli,G. Schepisi,N. Brighi,S. Severi

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. SUPPL 1 (2023): S327-S328

Cited0Views0Bibtex

1826P Lutetium-177-PSMA in Pre- and Post-Taxane Mcrpc Setting: Results from a Phase II Clinical Trial

E.F. Giunta,M. Sansovini,I. Grassi,I. Marini,N. Brighi,C. Lolli,G. Schepisi,S. Nicolini,F. Foca,M. Monti,M. Celli,P. Caroli,V. Di Iorio,A. Sarnelli,S. Severi,G. Paganelli,F. Matteucci,U.F.F. De Giorgi

Annals of Oncology (2023): S989

Cited0Views0Bibtex

Therapy with 177Lu-Psma-617 in Advanced Mcrpc Patients: Results of the Phase 2 Prospective Trial IRST-185.03 (EUDRACT: 2016-002732-32)

Marini I.,Sansovini M.,Paganelli G.,Grassi I.,Matteucci F.,Nicolini S.,De Giorgi U.,Giunta E.F.,Foca F.,Monti M.,Celli M.,Caroli P.,Di Iorio V.,Sarnelli A.,Lolli C.,Schepisi G.,Brighi N.,Severi S.

European urology open science (2023): S64-S64

Cited0Views0Bibtex

Radioligand Therapies in Cancer: Mapping the Educational Landscape in Europe

Valentina Bugani, Luca Battistelli,Maddalena Sansovini,Manuela Monti,Giovanni Paganelli,Ignasi Gich,Albert Flotats,Paola Anna Erba,Jean-Yves Blay,Christian la Fougère,Hendrik Van Poppel,Andreas Charalambous,Ken Herrmann,Alessandro Giordano,Tamás Györke,Christophe Deroose,Federica Matteucci,Ignasi Carrió

European journal of nuclear medicine and molecular imagingno. 9 (2023): 2692-2698

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn